Tori Marsh - November 17, 2017
Eliquis is a common anticoagulant medication that helps prevent blood clots, stroke, and pulmonary embolism. Common, but not cheap: cash prices average around $488 for a 30-day supply. Currently, there is no Eliquis generic alternative available, but one could be available as early as 2018. Since Eliquis tends to be a maintenance drug, taken for a longer period of time, it can break the bank.
If your doctor thinks Eliquis is right for you, how can you make it more affordable? Here’s some information on Eliquis and how you can save. See More
The GoodRx Pharmacist - June 19, 2017
Manufacturer Bristol-Myers Squibb has issued a voluntary recall of Eliquis, a commonly prescribed blood thinner. Eliquis can be used to reduce the risk of stroke due to atrial fibrillation, treat blood clots, prevent future blood clots, and decrease the risk of blood clots following surgery.
This is a class 1 recall, the most serious type of recall, which means that there is a situation where there is a reasonable probability that use of the recalled medication may cause serious adverse health consequences or death. See More
The GoodRx Pharmacist - April 18, 2017
If you have ever experienced a serious reaction to a medication, you are not alone. In 2000, the Institute of Medicine reported that more than 2 million serious adverse drug reactions occur each year. The FDA keeps track of these serious events through a reporting system and releases them quarterly. This system, the FDA Adverse Event Reporting System (FAERS), is a database that contains information on adverse events and medication error reports that have been submitted. See More
The GoodRx Pharmacist - February 25, 2017
Americans’ use of supplements, prescriptions and over the counter (OTC) medications has been steadily increasing over the past couple of years. This increase can sometimes put patients at risk for complications and interactions. Believe it or not, a lot of over-the-counter medications can actually interact with your prescription medications (and affect how they work) without you even realizing it. See More
Dr. Sharon Orrange - September 03, 2014
Doctors treating patients with atrial fibrillation have embraced the new oral anticoagulants and more than 60% of new prescriptions are now written for the newer choices instead of warfarin (Coumadin). Xarelto seems to be gaining speed as the dominating new blood thinner. Xarelto use has increased quickly, with more patients being treated with this drug than with warfarin or Pradaxa in 2013.
Here are 10 things you need to know about Xarelto:
1. See More
Dr. Sharon Orrange - April 02, 2014
Almost 6 million Americans have the irregular heart rhythm atrial fibrillation. Atrial fib increases your risk of stroke, heart failure, dementia, and early mortality. New guidelines have just been released, with some pretty big changes on how to manage atrial fib. Here is what you need to know:
1. Know the score.
The decision of whether or not you need to be on blood thinners when you have atrial fib has always been based on your score. See More
Dr. Sharon Orrange - February 12, 2014
Coumadin (warfarin) has been the mainstay of treatment for stroke prevention in folks with atrial fibrillation. When the atrium is fibrillating, and losing its atrial kick, there is a higher risk of clot forming in the atrium which will break off into the ventricle, then head to your brain and cause a stroke.
For that reason, we treat some folks with atrial fibrillation with blood thinners to prevent that stroke risk. See More
Dr. Sharon Orrange - December 19, 2013
The newer anticoagulants like Xarelto (rivaroxaban), known as Factor Xa inhibitors, save you from repeated blood tests for INR checks that you will need while on Coumadin (warfarin). Many folks wonder how they can change from Coumadin to the newer medications.
First, who can use Xarelto? Xarelto is a pill approved for use in folks with a known clot in their leg (deep venous thrombosis or DVT), a clot in their lung (pulmonary embolism or PE), prevention of clot/stroke in people with atrial fibrillation who do NOT have valve disease, and to decrease the risk of forming a clot in your leg or lung after hip or knee replacement surgery. See More